drugset / Trial / NCT03656692
Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)
NaSingle-groupOpen-labelTreatment
Summary
The main reason for this study is to see if Acthar Gel can reduce inflammation in the uvea. Also, safety information when using it for this purpose will be collected.
Timeline
- Start
- 2018-10-05
- Primary completion
- 2020-07-14
- Completion
- 2020-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | 80 iu | Subcutaneous |